SA
ARWR

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Arrowhead Pharmaceuticals Inc (ARWR)

Operating Income

-$707.17M

TTM · Period ending: · USD

ARWR logo

ARWR Operating Income

Latest reported-$707.17M
ARWR FY Operating Income (-$158.62K → -$707.17M)
Powered by
High-resolution chart · PNG

What is operating income?

Operating income is profit from the core business after operating costs, before interest and income taxes.

Compare operating income

ARWR operating income history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Arrowhead Pharmaceuticals Inc Operating Income — Annual fiscal periods (USD)
Period endingOperating Income (USD)Change
-707,171,000−819.06%
98,346,000—
-601,080,000—
-205,002,000—
-178,507,000—
-149,036,000—
-93,159,000−252.24%
61,191,000—
-55,936,235—
-36,995,909—
-81,742,726—
-95,973,976—
-53,276,286—
-24,589,276—
-21,089,211—
-9,830,266—
-8,802,049—
-19,560,005—
-35,002,581—
-37,949,172—
-20,483,382—
-9,592,848—
-2,690,833—
-94,438—
-1,416,214—
-106,265—
-109,235—
-56,216—
-24,299—
-158,619—

Frequently asked questions: ARWR operating income

What is Arrowhead Pharmaceuticals Inc (ARWR)'s current operating income?

Arrowhead Pharmaceuticals Inc (ARWR)'s latest reported operating income (TTM) is -$707.17M as of Sep 30, 2026. Operating income is profit from the core business after operating costs, before interest and income taxes.

How much historical operating income data is available for ARWR?

Stock Alarm Pro provides 30 dated annual fiscal periods observations for Arrowhead Pharmaceuticals Inc (ARWR)'s operating income, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare ARWR's operating income to peers or set an alert?

You can compare ARWR's operating income directly against sector peers (GH, BBIO, GKOS, BTSG) on Stock Alarm Pro, open the multi-ticker series in Chart Studio, or set real-time price and valuation alerts on ARWR delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.